3374-22-9 Usage
Description
2-Amino-3-mercaptopropionic acid, also known as Cysteine, is a sulfur-containing amino acid that is a derivative of propanoic acid with an amino group at the 2nd position and a sulfanyl group at the 3rd position. It is a white solid and can be synthesized by the human body under normal physiological conditions if there is a sufficient quantity of methionine available.
Uses
Used in the Food and Pharmaceutical Industries:
2-Amino-3-mercaptopropionic acid is used as a precursor in the food and pharmaceutical industries for various applications. It is used as a processing aid for baking, as an additive in cigarettes, and in the preparation of meat flavors.
Used in the Pharmaceutical Industry as an NMDA Agonist:
2-Amino-3-mercaptopropionic acid is used as an NMDA agonist at quisqualate receptors at high concentrations, which can have potential applications in the development of drugs targeting the nervous system.
Used in Chemical Synthesis:
Due to its unique chemical structure, 2-Amino-3-mercaptopropionic acid can be used as a building block in the synthesis of various organic compounds, particularly those requiring a sulfur-containing amino acid.
Used in Research and Development:
2-Amino-3-mercaptopropionic acid can also be utilized in research and development for studying its properties, interactions with other molecules, and potential applications in various fields, including medicine, agriculture, and materials science.
Biochem/physiol Actions
NMDA agonist that is an agonist at quisqualate receptors at high concentration.
Check Digit Verification of cas no
The CAS Registry Mumber 3374-22-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,3,7 and 4 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 3374-22:
(6*3)+(5*3)+(4*7)+(3*4)+(2*2)+(1*2)=79
79 % 10 = 9
So 3374-22-9 is a valid CAS Registry Number.
InChI:InChI=1/C3H7NO2S/c4-2(1-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m0/s1
3374-22-9Relevant articles and documents
MODIFIED INTERLEUKIN-7 PROTEINS AND USES THEREOF
-
, (2021/10/22)
Provided are a modified IL-7 polypeptide and a fusion protein containing the modified IL-7 polypeptide. The fusion protein of the modified IL-7 includes: a first domain containing an interleukin-7 polypeptide; a second domain containing an oligopeptide having 1 to 10 amino acid residues (with proviso that the second domain excludes the oligopeptide consisting of methionine and/or glycine); and (c) a third domain which prolongs the half-life of the IL-7 fusion protein. The modified IL-7 polypeptide is composed of the (a) first domain and the (b) second domain. The modified IL-7 polypeptide and the fusion protein are expressed in a higher yield than the wild-type IL-7 and shows increased stability.
Cysteine Chemistry in Connection with Abiogenesis
Bridoux, Maxime,Ceccarelli, Cecilia,Shalayel, Ibrahim,Vallée, Yannick,Vazart, Fanny,Youssef-Saliba, Sparta
supporting information, (2020/05/18)
Theoretical and experimental work has been conducted about possible prebiotic syntheses of cysteine. Activated derivatives of this amino acid can oligomerize and polymerize to afford various poly-thiazolines and cysteine-rich chains.
T Cells with Increased Immunosuppression Resistance
-
, (2018/02/06)
This invention relates to the treatment of cancer in an individual by administration of a population of modified T cells that express a recombinant cAMP phosphodiesterase (PDE) or a fragment thereof and an antigen receptor which binds specifically to cancer cells in the individual. Populations of modified T cells and methods of producing populations of modified T cells are provided, along with pharmaceutical compositions and methods of treatment
